ARTICLE | Finance
Venturing west
How newly formed Taiho Ventures plans to spend its $50 million fund
May 23, 2016 7:00 AM UTC
After two years as an LP, Taiho Pharmaceutical Co. Ltd. is taking the plunge and creating its own strategic venture unit. The company isn't providing many details about its $50 million Taiho Ventures, but the track record of newly appointed President Sakae Asanuma suggests the fund will include build-to-buy deals and spinouts.
Taiho Ventures will look for start-ups, with a focus on oncology therapeutics companies in the U.S., Europe and Japan...